Dilworth L, Facey A, Omoruyi F. Diabetes mellitus and its metabolic complications: the role of adipose tissues. Int J Mol Sci. 2021;22:7644.
Article CAS PubMed PubMed Central Google Scholar
Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci. 2013;9:191–200.
Article CAS PubMed PubMed Central Google Scholar
Kwon H, Pessin JE. Adipokines mediate inflammation and insulin resistance. Front Endocrinol. 2013;4:71.
Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N. Y Acad Sci. 1999;892:146–54.
Article CAS PubMed Google Scholar
Henry BA, Clarke IJ. Adipose tissue hormones and the regulation of food intake. J Neuroendocrinol. 2008;20:842–9.
Article CAS PubMed Google Scholar
Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes. 2001;50:1126–33.
Article CAS PubMed Google Scholar
Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116:1784–92.
Article CAS PubMed PubMed Central Google Scholar
Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001;7:947–53.
Article CAS PubMed Google Scholar
Wang Y, Meng RW, Kunutsor SK, Chowdhury R, Yuan JM, Koh WP, et al. Plasma adiponectin levels and type 2 diabetes risk: a nested case-control study in a Chinese population and an updated meta-analysis. Sci Rep. 2018;8:406.
Article PubMed PubMed Central Google Scholar
Halberg N, Henriksen M, Söderhamn N, Stallknecht B, Ploug T, Schjerling P, et al. Effect of intermittent fasting and refeeding on insulin action in healthy men. J Appl Physiol. 1985;99:2128–36.
Reyes-García R, Moreno-Pérez Ó, Tejera-Pérez C, Fernández-García D, Bellido-Castañeda V, de la Torre Casares ML, et al. Document on a comprehensive approach to type 2 diabetes mellitus. Endocrinol Diabetes Nutr. 2019;66:443–58.
Neuhouser ML, Schwarz Y, Wang C, Breymeyer K, Coronado G, Wang CY, et al. A low-glycemic load diet reduces serum C-reactive protein and modestly increases adiponectin in overweight and obese adults. J Nutr. 2012;142:369–74.
Article CAS PubMed Google Scholar
Mirmiran P, Hosseini S, Hosseinpour-Niazi S, Azizi F. Legume consumption increase adiponectin concentrations among type 2 diabetic patients: a randomized crossover clinical trial. Endocrinol Diabetes Nutr. 2019;66:49–55.
Grases F, Simonet BM, Prieto RM, March JG. Variation of InsP4. InsP5. InsP6 levels in tissues and biological fluids depending on dietary phytate. J Nutr Biochem. 2001;12:595–601.
Article CAS PubMed Google Scholar
Grases F, Simonet BM, Vucenik I, Prieto RM, Costa-Bauzá A, March JG, et al. Absorption and excretion of orally administered inositol hexaphosphate (IP6 or phytate) in humans. BioFactors. 2001;15:53–61.
Article CAS PubMed Google Scholar
Grases F, Costa-Bauzá A, Berga F, Gomila RM, Martorell G, Martínez-Cignoni MR. Intake of myo-inositol hexaphosphate and urinary excretion of inositol phosphates in Wistar rats: gavage vs. oral administration with sugar. PLoS ONE. 2019;14:e0223959.
Article CAS PubMed PubMed Central Google Scholar
Grases F, Isern B, Perelló J, Sanchis P, Prieto RM, Costa-Bauzà A. Absorption of myo-inositol hexakisphosphate (InsP6) through the skin in humans. Pharmazie. 2006;61:652.
Grases F, Isern B, Perelló J, Sanchis P, Prieto RM. Absorption of myo-inositol hexakisphosphate (InsP6) through the skin: study of the matrix effects. mechanism of phytate topical absorption. Front Biosci. 2005;10:799–802.
Article CAS PubMed Google Scholar
Vanderlinden K, Vucenik I. Too good to be true? Inositol + cal mag IP6. Mississauga, ON, Canada: Bearing Marketing Communications Limited; 2004.
Zhou JR, Erdman JW Jr. Phytic acid in health and disease. Crit Rev Food Sci Nutr. 1995;35:495–508.
Article CAS PubMed Google Scholar
Dilworth LL, Omoruyi FO, Simon OR, Morrison EY, Asemota HN. The effect of phytic acid on the levels of blood glucose and some enzymes of carbohydrate and lipid metabolism. West Indian Med J. 2005;54:102–6.
Article CAS PubMed Google Scholar
Omoruyi FO, Budiaman A, Eng Y. The potential benefits and adverse effects of phytic acid supplement in streptozotocin-induced diabetic rats. Adv Pharm Sci. 2013;2013:172494.
Sanchis P, Buades JM, Berga F, Gelabert MM, Molina M, Íñigo MV, et al. Protective effect of myo-inositol hexaphosphate (phytate) on abdominal aortic calcification in patients with chronic kidney disease. J Ren Nutr. 2016;26:226–36.
Article CAS PubMed Google Scholar
Prieto RM, Fiol M, Perello J, Estruch R, Ros E, Sanchis P, et al. Effects of Mediterranean diets with low and high proportions of phytate-rich foods on the urinary phytate excretion. Eur J Nutr. 2010;49:321–6.
Article CAS PubMed Google Scholar
Berga F, Rodriguez A, Costa-Bauzá A, Grases F. Novel colorimetric determination of phytate in urine. Anal Lett. 2016;49:307–18.
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995;5:289–300.
McDonald JH. Handbook of Biological Statistics. 3rd ed. Baltimore, Maryland,: Sparky House Publishing; 2014.
Sanchis P, Rivera R, Berga F, Fortuny R, Adrover M, Costa-Bauza A, et al. Phytate decreases formation of advanced glycation end-products in patients with type II diabetes: randomized crossover trial. Sci Rep. 2018;8:9619.
Article PubMed PubMed Central Google Scholar
Croze ML, Géloën A, Soulag CO. Abnormalities in myo-inositol metabolism associated with type 2 diabetes in mice fed a high-fat diet: benefits of a dietary myo-inositol supplementation. Br J Nutr. 2015;113:1862–75.
Article CAS PubMed Google Scholar
Okazaki Y, Sekita A, Katayama T. Intake of phytic acid and myo-inositol lowers hepatic lipogenic gene expression and modulates gut microbiota in rats fed a high-sucrose diet. Biomed Rep. 2018;8:466–74.
CAS PubMed PubMed Central Google Scholar
Kim JN, Han SN, Kim HK. Phytic acid and myo-inositol support adipocyte differentiation and improve insulin sensitivity in 3T3-L1 cells. Nutr Res. 2014;34:723–31.
Article CAS PubMed Google Scholar
Hauner H. The mode of action of thiazolidinediones. Diabetes Metab Res Rev. 2002;18:S10–5.
Article CAS PubMed Google Scholar
Ye J. Mechanisms of insulin resistance in obesity. Front Med. 2013;7:14–24.
Article PubMed PubMed Central Google Scholar
Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes. 2009;33:54–66.
Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pr. 2014;105:141–50.
Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:2045–51.
Article CAS PubMed PubMed Central Google Scholar
Silva D, Pais de Lacerda A. Proteína C reativa de alta sensibilidade como biomarcador de risco na doença coronária [High-sensitivity C-reactive protein as a biomarker of risk in coronary artery disease]. Rev Port Cardiol. 2012;31:733–45.
Ruan H, Lodish HF. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev. 2003;14:447–55.
Article CAS PubMed Google Scholar
Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther. 2006;8(Suppl 2):S3.
Robinson K, Prins J, Venkatesh B. Clinical review: adiponectin biology and its role in inflammation and critical illness. Crit Care. 2011;15:221.
Article PubMed PubMed Central Google Scholar
Omoruyi FO, Stennett D, Foster S, Dilworth L. New frontiers for the use of IP6 and inositol combination in treating diabetes mellitus: a review. Molecules. 2020;25:1720.
留言 (0)